2021
DOI: 10.1016/s146532492100400x
|View full text |Cite
|
Sign up to set email alerts
|

Rapid manufacture of cd19 car t cells in an automated system for treatment of non-hodgkin lymphoma results in long term persistence in vivo

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles